Cat. No. | Product name | CAS No. |
DC5013 |
AZD3514
AZD3514 is a potent and oral androgen receptor with Ki of 2.2 μM and has ability of reducing AR protein expression. |
1240299-33-5 |
DC9268 |
AZD9496
Featured
AZD9496 is a potent and orally bioavailable selective estrogen receptor downregulator(Ki=0.7 nM) and antagonist. |
1639042-08-2 |
DC11541 |
AZD-9567
AZD-9567 (AZD9567) is a potent, selective, non-steroidal and orally available selective glucocorticoid receptor modulator (SGRM) for treatment of rheumatoid arthritis.. |
1893415-00-3 |
DC11542 |
AZD-9567 monohydrate
AZD-9567 (AZD9567) is a potent, selective, non-steroidal and orally available selective glucocorticoid receptor modulator (SGRM) for treatment of rheumatoid arthritis.. |
1893415-64-9 |
DC11032 |
AZD9977
Featured
AZD9977 is a first-in-class, potent, selective, mineralocorticoid receptor (MR) modulator with IC50 of 0.37. 0.08 and 0.08 uM for human, mouse and rat MR, respectively. |
1850385-64-6 |
DC4135 |
Bardoxolone methyl
Featured
Bardoxolone methyl (also known as “RTA 402” and “CDDO-methyl ester”) is an orally-available first-in-class synthetic triterpenoid belonging to the antioxidant inflammation modulator (AIM) class. |
218600-53-4 |
DC7372 |
Bazedoxifene-Acetate
Featured
Bazedoxifene acetate (TSE 424; WAY-TES 424), a novel selective estrogen receptor modulator (SERM), has been developed to have favorable effects on bone and the lipid profile while minimizing stimulation of uterine or breast tissues. |
198481-33-3 |
DC8922 |
Bazedoxifene
Featured
Bazedoxifene is a selective estrogen receptor modulator (SERM) currently in development for osteoporosis prevention and treatment. |
198481-32-2 |
DC9088 |
Bezafibrate
Bezafibrate(BM15075) is the first clinically tested dual and pan-PPAR co-agonism. |
41859-67-0 |
DC9252 |
BMS-687453
Featured
BMS687453 is a potent and selective peroxisome proliferator activated receptor (PPAR) α agonist, with an EC50 of 10 nM for human PPARα and ∼410-fold selectivity vs human PPARγ in PPAR-GAL4 transactivation assays. |
1000998-59-3 |
DC9861 |
BMS-779788(XL-652)
Featured
BMS-779788(XL652) is a novel small-molecule modulator of the Liver X Receptor (LXR), a nuclear hormone receptor implicated in a variety of cardiovascular and metabolic disorders. |
918348-67-1 |
DC9547 |
Boldenone Undecylenate
Boldenone undecylenate(Equipoise) is a synthetic steroid which has a similar effect as the natural steroid testosterone; it is frequently used in veterinary medicine, though it is also used in humans. |
13103-34-9 |
DC11499 |
BPK-29
BPK-29 is a covalent, specific small molecule that disrupts NR0B1 protein complexes and impairs the anchorage-independent growth of KEAP1-mutant cancer cells. |
2143467-62-1 |
DC10913 |
Brusatol
Brusatol (NSC 172924, (+)-Brusatol) is a quassinoid extracted from Brucea Esters, can inhibit HIF-1 signaling pathway, also is a potent Nrf2 inhibitor. |
14907-98-3 |
DC11493 |
C2BA-4
C2BA-4(C2BA 4) is a potent, specific human Pregnane X receptor (hPXR) activator with EC50 of 49 nM. |
712333-04-5 |
DCAPI1559 |
Calcifediol
Featured
Calcifediol is a major circulating metabolite of vitamin D3, acting as a competitive inhibitor with an apparent Ki of 3.9 μM, suppresses PTH secretion and mRNA (ED50=2 nM). |
19356-17-3 |
DCAPI1415 |
Calcipotriol(Calcipotriene)
Featured
Calcipotriol is a synthetic VitD3 analogue with a high affinity for the vitamin D receptor. |
112965-21-6 |
DCAPI1150 |
Calcitriol (Rocaltrol)
Featured
Calcitriol is the most active metabolite of vitamin D and also a vitamin D receptor (VDR) agonist. |
32222-06-3 |
DC4160 |
CB-03-01
Featured
CB-03-01 is a steroidal ester, androgen antagonist derived from 11-deoxycortisone, which tightly mimics the profile of an ideal anti-androgen for topical use. |
19608-29-8 |
DC10617 |
CBL0137
Featured
CBL0137 is a metabolically stable curaxin that activates p53 with an EC50 value of 0.37 µM and inhibits NF-κB with an EC50 of 0.47 µM. |
1197996-80-7 |
DC10955 |
CD12681
CD12681 (CD-12681) is a potent, selective RORγ inverse agonist with IC50 of 19 nM, displays no activity against a panel of nuclear receptors (RORα, RARγ, LXRβ, PPARγ and VDR). |
1952239-59-6 |
DC10491 |
CD437
Featured
CD437 is a synthetic retinoid that is an RARγ-selective agonist. It displays RARγ-dependent and -independent effects on differentiation and apoptosis. |
125316-60-1 |